The global cardiometabolic disease market reached USD 34.10 Billion in 2024 and is projected to grow at a CAGR of 5.40% to USD 57.70 Billion by 2034. Growth is driven by the increasing prevalence of obesity, diabetes, cardiovascular diseases, and aging populations across major markets. https://www.expertmarketresearch.com/reports/cardiometabolic-disease-market